HealthSouth Corporation (HLS) Stock Rating Reaffirmed by Royal Bank Of Canada
HealthSouth Corporation (NYSE:HLS)‘s stock had its “buy” rating restated by investment analysts at Royal Bank Of Canada in a research note issued on Wednesday.
Other equities analysts have also recently issued reports about the stock. Stephens started coverage on shares of HealthSouth Corporation in a research note on Thursday, August 31st. They set an “overweight” rating and a $53.00 price target on the stock. Zacks Investment Research raised shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. KeyCorp reaffirmed a “hold” rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. ValuEngine cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $50.00 price target on shares of HealthSouth Corporation in a research note on Sunday, September 17th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $51.75.
Shares of HealthSouth Corporation (HLS) traded up $0.28 during trading on Wednesday, hitting $48.32. 2,068,600 shares of the stock were exchanged, compared to its average volume of 913,596. The firm has a market cap of $4,722.85, a PE ratio of 17.22, a price-to-earnings-growth ratio of 1.77 and a beta of 0.52. HealthSouth Corporation has a fifty-two week low of $38.24 and a fifty-two week high of $49.99. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.
HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. The company had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. HealthSouth Corporation had a net margin of 6.69% and a return on equity of 22.81%. HealthSouth Corporation’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.65 EPS. equities analysts expect that HealthSouth Corporation will post 2.72 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “HealthSouth Corporation (HLS) Stock Rating Reaffirmed by Royal Bank Of Canada” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/healthsouth-corporation-hls-stock-rating-reaffirmed-by-royal-bank-of-canada/1710178.html.
In other HealthSouth Corporation news, Director Yvonne M. Curl acquired 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The shares were acquired at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the transaction, the director now directly owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by insiders.
A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in HealthSouth Corporation by 4.6% in the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock valued at $364,571,000 after purchasing an additional 328,081 shares in the last quarter. William Blair Investment Management LLC lifted its holdings in HealthSouth Corporation by 13.9% in the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after purchasing an additional 525,767 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in HealthSouth Corporation by 0.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,035,977 shares of the company’s stock valued at $186,946,000 after purchasing an additional 33,201 shares in the last quarter. State Street Corp lifted its holdings in HealthSouth Corporation by 7.5% in the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock valued at $151,479,000 after purchasing an additional 219,306 shares in the last quarter. Finally, Voya Investment Management LLC lifted its holdings in HealthSouth Corporation by 4.4% in the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock valued at $78,485,000 after purchasing an additional 68,486 shares in the last quarter. Institutional investors own 93.60% of the company’s stock.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.